Skip to product information
1 of 1

GeneBio Systems

Recombinant Mouse VCAM-1/CD106 Protein(Fc Tag)

Recombinant Mouse VCAM-1/CD106 Protein(Fc Tag)

SKU:PDMM100163

Regular price $1,229.76 CAD
Regular price Sale price $1,229.76 CAD
Sale Sold out
Shipping calculated at checkout.

Size:100μg

Storage:Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Shipping:This product is provided as lyophilized powder which is shipped with ice packs.

Exp date:12 months

Category ID_II:Recombinant Proteins

Category ID_III:Immune Checkpoint Proteins

Abbreviation:VCAM-1/CD106

Target Synonym:MGC;Vascular cell adhesion protein;Vascular Cell Adhesion Molecule;VCMA;V-CAM;CD106;CD106 Antigen;INCAM 100;INCAM-100;L1CAM;MGC99561;Vascular Cell Adhesion Molecule 1;Vascular cell adhesion protein 1;VCAM 1;V-CAM 1;VCMA1;Vcam-1;Vcam1;CD106;INCAM-100;vascular cell adhesion molecule 1

Research Areas:

Conjugation:

Target Species:Mouse

Expression Host:Mammalian

Application:

Fusion tag:C-Fc

UNIProt ID:P29533

Accession:P29533

Background:Vascular cell adhesion molecule 1 (VCAM-1) , also known as CD106 , is a cell surface sialoglycoprotein belonging to the immunoglobulin superfamily. Two forms of VCAM-1 with either six or seven extracellular Ig-like domains are generated by alternative splicing , with the longer form predominant. VCAM-1 is an endothelial ligand for very late antigen-4 (VLA-4) and α4ß7 integrin expressed on leukocytes , and thus mediates leukocyte-endothelial cell adhesion and signal transduction. VCAM-1 expression is induced on endothelial cells during inflammatory bowel disease , atherosclerosis , allograft rejection , infection , and asthmatic responses. During these responses , VCAM-1 forms a scaffold for leukocyte migration. VCAM-1 also activates signals within endothelial cells resulting in the opening of an "endothelial cell gate" through which leukocytes migrate. VCAM-1 has been identified as a potential anti-inflammatory therapeutic target , the hypothesis being that reduced expression of VCAM-1 will slow the development of atherosclerosis. In addition , VCAM-1-activated signals in endothelial cells are regulated by cytokines indicating that it is important to consider both endothelial cell adhesion molecule expression and function during inflammatory processes.

Concentration:

Activity:Not validated for activity

Sequence:Met1-Glu698

Purity: > 90% as determined by reducing SDS-PAGE.

Formulation:Lyophilized from a 0.2 μm filtered solution in PBS with 5% Trehalose and 5% Mannitol.

Reconstitution:It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis.

Endotoxin:< 1.0 EU/mg of the protein as determined by the LAL method.

Calculated MW:101.6 kDa

ObservedMW:102 kDa

View full details